Skip to main content

Table 1 Baseline characteristics in the FAS

From: Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K)

Parameter

FASa

(N = 600)

Demographics

 Age, years

  Mean (SD)

54.3 (12.9)

  Median (IQR)

55.0 (45.0–63.5)

 Sex, n (%)

  Male

403 (67.2)

Disease characteristics and concomitant conditions

 Aetiology of ESRD, n (%)

  Primary glomerulonephritis

188 (38.8)

  Diabetic kidney disease

135 (27.8)

  Hypertensive renal disease

77 (15.9)

 Any medical historyb, n (%)

599 (99.8)

  Hyperkalaemia

360 (60.0)

  Renal anaemia

487 (81.2)

  Hypertension

487 (81.2)

  Hyperphosphataemia

277 (46.2)

  Diabetes mellitus

119 (19.8)

  Metabolic acidosis

79 (13.2)

  Hyperlipidaemia

75 (12.5)

  Coronary artery disease

75 (12.5)

  Hyperuricaemia

61 (10.2)

Dialysis parameters

 Type of haemodialysis, n (%)

  Haemodialysis

529 (88.3)

  Haemodiafiltration

60 (10.0)

  Haemoperfusion combined with haemodialysis or haemodiafiltration

10 (1.7)

 Vascular access, n (%)

  Arteriovenous fistula

568 (94.8)

  Central tunnelled dialysis catheter

14 (2.3)

  Arteriovenous graft

9 (1.5)

  Other (temporary catheter)

8 (1.3)

 Dialysis frequency, n (%)

  Three-times weekly

513 (85.6)

  Five times every 2 weeks

50 (8.3)

  Twice weekly

36 (6.0)

 Dialysate potassium concentration, mmol/L

  Mean (SD)

2.0 (0.14)

  Median (IQR)c

2.0 (2.0–2.0)

 Haemodialysis duration, hours

  Mean (SD)

4.0 (0.16)

  1. ESRD end-stage renal disease, FAS full analysis set, IQR interquartile range, SD standard deviation
  2. aAetiology of ESRD (n = 485; 115 missing); medical history and all dialysis parameters (n = 599; one missing)
  3. cRange: 2.0–3.0 mmol/L